Predictions
Orpea Nom.
Start price
Target price
Perf. (%)
€36.36
19.02.22
19.02.22
€32.00
19.02.23
19.02.23
-5.42%
05.03.22
05.03.22
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€7.83
09.02.22
09.02.22
-
09.02.23
09.02.23
-12.11%
18.02.22
18.02.22
Probably not worthwhile Investment
Orpea Nom.
Start price
Target price
Perf. (%)
€34.38
06.02.22
06.02.22
€31.00
06.02.23
06.02.23
5.76%
19.02.22
19.02.22
Risky Investment
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€6.22
06.02.22
06.02.22
-
06.02.23
06.02.23
-15.28%
20.02.22
20.02.22
Risky Investment
Teladoc Health Inc
Start price
Target price
Perf. (%)
€64.00
30.01.22
30.01.22
€65.00
30.01.23
30.01.23
-27.22%
14.03.22
14.03.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Quoin Pharmaceuticals Ltd. ADR
Start price
Target price
Perf. (%)
€13.88
25.01.22
25.01.22
€25.00
25.01.23
25.01.23
9.01%
05.02.22
05.02.22
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
Teladoc Health Inc
Start price
Target price
Perf. (%)
€60.46
24.01.22
24.01.22
€52.00
24.01.23
24.01.23
5.86%
30.01.22
30.01.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Canopy Growth Corp
Start price
Target price
Perf. (%)
€6.43
23.01.22
23.01.22
-
23.01.23
23.01.23
7.21%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€130.15
12.01.22
12.01.22
-
12.01.23
12.01.23
12.55%
13.01.23
13.01.23
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€130.15
12.01.22
12.01.22
-
12.01.23
12.01.23
0.00%
12.01.22
12.01.22
Teladoc Health Inc
Start price
Target price
Perf. (%)
€75.84
11.01.22
11.01.22
€82.00
11.01.23
11.01.23
-20.28%
24.01.22
24.01.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Novocure Ltd
Start price
Target price
Perf. (%)
€59.26
09.01.22
09.01.22
€51.00
09.01.23
09.01.23
8.34%
16.03.22
16.03.22
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
MorphoSys AG
Start price
Target price
Perf. (%)
€30.80
08.01.22
08.01.22
-
08.01.26
08.01.26
-46.20%
05.09.22
05.09.22
Probably not worthwhile Investment
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€136.00
28.12.21
28.12.21
€142.00
28.12.22
28.12.22
-70.42%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
Opko Health Inc.
Start price
Target price
Perf. (%)
€4.65
28.12.21
28.12.21
-
28.12.22
28.12.22
-75.54%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Future proof or reliable business model
Uniqure B.V.
Start price
Target price
Perf. (%)
€19.00
27.12.21
27.12.21
-
27.12.22
27.12.22
8.55%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€143.65
27.12.21
27.12.21
-
27.12.22
27.12.22
-9.78%
09.01.22
09.01.22
Risky Investment
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.99
27.12.21
27.12.21
€42.00
27.12.22
27.12.22
-5.05%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Teladoc Health Inc
Start price
Target price
Perf. (%)
€86.38
20.12.21
20.12.21
€66.00
20.12.22
20.12.22
-12.20%
11.01.22
11.01.22
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Evotec SE ADR
Start price
Target price
Perf. (%)
€21.40
16.12.21
16.12.21
-
16.12.25
16.12.25
-60.75%
12.01.24
12.01.24
Could be worthwhile Investment >10% per year
Neogen Corp.
Start price
Target price
Perf. (%)
€35.40
14.12.21
14.12.21
€38.00
14.12.22
14.12.22
-59.89%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year